MYP_134776
Basic Information
BAY55-9837 (VPAC2 receptor agonist)
Hormonal / Endocrine Hormone peptide
Standard
31 amino acids
C167H269N51O47
Standard
Sequence
HSDAVFTDNYTRLRKQVAAKKYLQSIKNKRY
Physicochemical Analysis
3743.24 Da
10.21
5.84
5.57
0.1884
-1.14
0.60
-0.37
56.02
66.13
0.1290
4470.00
4470.00
The radar chart summarizes major physicochemical dimensions for quick comparison, while exact numerical values remain listed on the left.
Residue Composition
Amino Acid Composition
Chemical Descriptors
1669.37
-17.08
60.0
54.0
129.0
265.0
5.0
34.0
Structural Visualization
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber in the current view mode. Use the buttons to zoom.
2D CHEMICAL STRUCTURE
Drag to move
Drag to move. Use the buttons to zoom.
Experimental Records
RECORD: Rec_0067825 VERIFIED: YES
Provenance & Taxonomy
not reported [other]
PACAP
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
None
None
Bio-Activity Profile
Insulin secretion stimulant
glucose -stimulated 1st phase insulin secretion in BAY55-9837-treated mice (20nmol/kg) is 0.79 fold higher than control
0.02 μM
HPLC-ESI/MS/MS
Protein Sample +HAS + Fxa +DPP IV, in vitro; 250.8 s
RECORD: Rec_0399230 VERIFIED: YES
Provenance & Taxonomy
not reported [other]
PACAP
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
None
None
Bio-Activity Profile
Insulin secretion stimulant
glucose -stimulated 1st phase insulin secretion in BAY55-9837-treated mice (20nmol/kg) is 0.79 fold higher than control
0.02 μM
LC-MS/MS
New Zealand White Rabbit plasma (Dose i/v injected), in vivo; ~300 s